N.W. Fulcher Limited Acquires Convertible Debentures of Nova Leap Health Corp.
The Debentures were purchased by way of a private placement and were acquired for investment purposes. Fulcher may, from time to time, increase or decrease its holdings of securities of Nova Leap, depending on market and other conditions.Fulcher’s acquisition of the Debentures, assuming exercise of the 1,025,000 warrants to acquire common shares held by Fulcher (the “Warrants”) and conversion of the Debentures into common shares of Nova Leap, represents approximately 2.98% of the common shares of Nova Leap issued and outstanding.Immediately before the acquisition, Fulcher and its joint actors owned 9,508,333 common shares of Nova Leap and the Warrants. Assuming conversion of the Warrants, the aggregate number of common shares of Nova Leap held by Fulcher and its joint actors before the acquisition represented approximately 16.80% of all issued and outstanding common shares of Nova Leap.Following the acquisition and assuming exercise of the Warrants and conversion of the Debentures, Fulcher and its joint actors now own 12,456,409 common shares of Nova Leap, which represents approximately 19.28% of all issued and outstanding common shares of Nova Leap.Further details on the information above concerning Fulcher may be obtained from the Early Warning Report filed on SEDAR or by contacting Christopher Dobbin, President & CEO of Nova Leap Health Corp. at 902.401.9480.